Verified July 2026 · Cited to primary sources
Cerebrolysin: Evidence Grade C. Early / foreign human data only.
The honest verdict
Cerebrolysin is the most legitimately studied peptide in this batch and is a genuinely approved drug in several countries, which sets it apart from the research-chemical crowd. But the evidence is honestly mixed: the big stroke meta-analyses were neutral, and the stronger cognitive results in vascular dementia come from trials of variable quality. It is not FDA approved, so in the US it is research-only. Real drug abroad, real trials, real caveats.
Cerebrolysin at a glance
- Class
- Neuropeptide preparation (porcine brain-derived)
- Mechanism
- Cerebrolysin is not a single peptide but a standardized mixture of low-molecular-weight neuropeptides and amino acids produced by enzymatic breakdown of purified pig brain protein. It is proposed to act like a neurotrophic factor, supporting neuron survival, plasticity, and repair. It is given intravenously, usually in treatment cycles. Because it is a complex biological mixture rather than a defined molecule, its exact active components are not fully characterized.
- Also known as
- Cerebrolysin, FPF-1070, porcine brain-derived peptide preparation
- Research applications
- Acute ischemic stroke and neurorecovery
- Vascular dementia and Alzheimer's disease
- Traumatic brain injury
- Cognitive decline
- Forms
- Intravenous infusion, Intramuscular injection
- Legal status
- Research-only
- WADA (anti-doping)
- Not specifically named on the WADA Prohibited List.
- Evidence grade
- Grade CEarly / foreign human data only
How we grade evidence
Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is Cerebrolysin?
A peptide mixture derived from pig brain that is actually approved and used for stroke and dementia in several countries, just not the US. It has a real stack of human trials, but the quality is mixed and the biggest stroke analyses came back neutral.
Cerebrolysin is not a single peptide but a standardized mixture of low-molecular-weight neuropeptides and amino acids produced by enzymatic breakdown of purified pig brain protein. It is proposed to act like a neurotrophic factor, supporting neuron survival, plasticity, and repair. It is given intravenously, usually in treatment cycles. Because it is a complex biological mixture rather than a defined molecule, its exact active components are not fully characterized.
How strong is the evidence for Cerebrolysin?
Cerebrolysin sits at C: it has genuine human randomized controlled trials, including positive ones, but the overall body of evidence is mixed and the strongest signals are in the softer indications. In acute ischemic stroke, meta-analyses of randomized trials (over 1,700 patients pooled) failed to show significant superiority over placebo on core functional outcomes like the modified Rankin Scale and Barthel Index, though safety was neutral. The more convincing data is in vascular dementia: a randomized, double-blind, placebo-controlled multicenter trial in 242 patients showed a clear cognitive benefit (ADAS-cog+ improved 10.6 vs 4.4 points at 24 weeks, p<0.0001), and a meta-analysis pooled a beneficial cognitive effect. Real human RCTs, mixed results, foreign approval but no FDA approval, and methodological quality that varies by study. That is a textbook C.
Primary sources (2)
- Guekht et al. 2011, J Stroke Cerebrovasc Dis - Cerebrolysin in vascular dementia: randomized, double-blind, placebo-controlled multicenter trial (242 patients; ADAS-cog+ improved 10.6 vs 4.4 points at 24 weeks, p<0.0001)
- Zhang et al. 2017, Biomed Res Int - Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: Meta-Analysis of RCTs (7 trials, 1,779 patients; NO significant superiority over placebo on mRS/Barthel Index, neutral safety)
Is Cerebrolysin legal? (Status July 2026)
No legal supervised US route.
What is Cerebrolysin used for?
Cerebrolysin is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.
What does Cerebrolysin cost, and how do you access it legally?
Typical cost
$60 to $200 per treatment course depending on country and source
Priced as an actual pharmaceutical where it is approved abroad. In the US there is no legal supply, so any cost reflects unregulated import rather than a prescribed medicine.
No legal supervised access route right now.
Cerebrolysin has no compliant US route today. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole, so we don't link them. If you pursue Cerebrolysin, do it with a licensed clinician, and re-check its legal status first.
Is Cerebrolysinsafe? Side effects & risks
Cerebrolysin is approved and marketed in a number of countries in Europe, Asia, and the former Soviet region, where it has been used clinically for decades, and its trials generally report only non-serious adverse events with no significant excess over placebo. However, in the United States it is NOT FDA approved and cannot be legally compounded or prescribed, so any US access is through unregulated import (research-only status here). It is a porcine brain-derived biological, which carries the usual considerations of a pooled animal-tissue product. Ex-US approval does not equal US legality.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Cerebrolysin FAQ
Does cerebrolysin work for stroke?
The evidence is mixed and leans neutral. Meta-analyses pooling over 1,700 stroke patients did not find a significant benefit over placebo on core recovery measures like the modified Rankin Scale, though it appeared safe.
Does cerebrolysin help with dementia?
This is its strongest data. A 242-patient randomized controlled trial in vascular dementia showed a meaningful cognitive improvement at 24 weeks versus placebo, and a meta-analysis found a beneficial cognitive effect. Quality across trials still varies.
Is cerebrolysin FDA approved?
No. It is approved and used in a number of countries in Europe and Asia, but it is not FDA approved in the United States, where it cannot be legally compounded or prescribed and is effectively research-only.
Is cerebrolysin safe?
Trials generally report only non-serious side effects with no significant excess over placebo, and it has a long clinical history abroad. It is a porcine brain-derived biological, and in the US there is no regulated supply.
From our portfolio
Tracking Cerebrolysin?
Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.
Keep reading
Semax
A Russian-approved cognitive and neuroprotective peptide with real but non-Western clinical data.
Grade CSelank
A Russian-developed anti-anxiety and nootropic peptide with real but non-Western human trials. In Russian studies it matched a benzodiazepine for anxiety without the sedation or dependence.
Grade DDihexa
A lab-built angiotensin IV analog designed to supercharge brain synapse formation, and in rats it looked staggeringly potent. But it has never been proven in a human, and the drug company version built on the same target failed its big Alzheimer's trial in 2024.
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.